In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


This content is currently on FREE ACCESS, enjoy another 58 days of free consultation

 

Cardiogenic shock in intensive medicine care: are the old scores still useful?

Session Poster Session 3

Speaker Hugo Miranda

Congress : Heart Failure 2019

  • Topic : heart failure
  • Sub-topic : Acute Heart Failure - Epidemiology, Prognosis, Outcome
  • Session type : Poster Session
  • FP Number : P1761

Authors : H Miranda (Lisboa,PT), I Milet (Vila Real,PT), N Barros (Vila Real,PT), I Militao (Vila Real,PT), F Esteves (Vila Real,PT)

15 views

Authors:
H Miranda1 , I Milet2 , N Barros2 , I Militao2 , F Esteves2 , 1Hospitalar Center Barreiro-Montijo - Lisboa - Portugal , 2Hospital Center of Tras-os-Montes and Alto Douro, Intensive Medicine - Vila Real - Portugal ,

Citation:

Introduction:

Cardiogenic shock (CS) is a state of critical end-organ hypoperfusion due to primary cardiac dysfunction. Several clinical and biological factors have been used for prognosis assessment. Those factors have been recently regrouped into scores combining independent parameters—the Sleeper, CardShock and IABP-SHOCK II  score, which aren’t used daily in general ICU.

Objectives:

Evaluate usefulness of SOFA, APACHE II and SAPS II scores in predicting the outcome in CS patients (P) and identify the most useful one, if applicable.

Methods:

Retrospective analysis of P admitted in our ICU, with confirmed diagnosis of CS, within a period of 5 years. We analyzed common epidemiological variables, evolution during ICU stay, established therapeutics and outcome. wE estimated SOFA, APACHE II and SAPS II score at admission and discharge when applicable.

Results:

90 P were included. Mean age of 69,59 ± 12,23 years, with a predominance of males (56,7%). Admission SOFA of 10,39 ± 3,19. The main cause of CS was non-ischemic, with only 33,3% caused by acute coronary syndromes. 68,9% needed mechanical invasive ventilation in the first 24h, maximum PEEP used of 8,22±2,76. VCPVG was the most used ventilatory mode, with median weaning time of 3 days. PaO2/FiO2 ratio and lactactes at admission of 178,5 and 2,85, respectively. All the P needed aminergic support. Renal replacement therapy was used in 34,4% P. Step-up and step-down in ICU unit in 6,7 and 26,7% of the cases, respectively. Infectious intercurrence (nosocomial infection) in 35,51% cases.  Limitation of the therapeutic effort in 42,22% P.

At discharge, P presented median ICU stay of 5 days (hospital stay of 10,5 days) with SOFA, APACHE II and SAPS II of 7.6±5,06, 24,5 and 56,61 ± 19,71, respectively. Hospital mortality of 45,6%.

We found a statistically significant association between outcome and: 1) admission SOFA (p=0,006), 2) APACHE II (p<0,001), 3) SAPS II (p< 0,001). We also point out that after applying a logistic regression only APACHE II (OR: 1,13; IC95%: 1,028-1,253) had relevant prediction power.

Conclusion

In our study, we found that APACHE II was the only score capable of predicting the outcome of our P. It provides an estimate of ICU mortality based on a number of laboratory values and patient signs taking both acute and chronic disease into account.



Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, and Novartis Pharma AG. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are